Detection Rate of 18F-choline-PET/CT and 68Ga-PSMA-HBED-CC-PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes.

Introduction: Accurate detection of prostate cancer lymph node (LN) metastases (LNM) through PET/CT prior to lymphadenectomy (LA) is crucial for successful therapy. PET/CT with choline-derivatives used to be the standard tool for imaging metastases, whereas 68Ga-PSMA-(prostate-specific membrane antigen)-PET/CT was introduced recently. Both PET-techniques were investigated with respect to what extent the detection rate of LNM depends on the size of tumor deposits (TD) within LNM. Methods: Documenting the switch from the use of 18F-choline to 68Ga-PSMA in 2014, we used two patient cohorts undergoing a template LA because of a PET/CT indicating LNM. 44 and 40 patients had PET/CT with 18F-choline or 68Ga-PSMA-ligand. 226 LNM (125 18F-choline, 101 68Ga-PSMA) originated from 73 salvage LAs at biochemical recurrence and from 11 primary LAs at radical prostatectomy. LNM eligible for direct correlation of PET/CT to histopathology were identified from LAs conducted in small anatomical subregions with 1 LNM (condition 1) or 1-2 LNM (condition 2). Longitudinal and short diameter of TD within LNM were determined by histopathology allowing to link the size of TD in LNM to the detection threshold of PET/CT. Diameters associated with a detection rate of 50% and 90% (d50%, d90%) were calculated based on logistic growth curve models fitted. Results: Gleason-score, number of removed LN and subregions for LA per patient did not differ significantly between the 18F-choline-and 68Ga-PSMA-group. Median PSA-level at imaging and number of LNM per patient was significantly higher in the 18F-choline-group (3.4 ng/ml, n = 34) compared to the 68Ga-PSMA-group (2.2 ng/ml, n = 28; both p<0.05). Longitudinal respectively short diameters of TD in LNM to reach d90% was 11.2 mm respectively 7.4 mm for 18F-choline-PET/CT and 6.3 mm respectively 4.9 mm for 68Ga-PSMA-PET/CT. Corresponding diameters to reach d50% were 5.5 mm and 3.3 mm for 18F-choline-PET/CT and 3.7 mm and 2.3 mm for 68Ga-PSMA-PET/CT, respectively. Detection rates were significantly higher under 68Ga-PSMA (P = 0.005 and P = 0.04 for longitudinal and short diameter). Conclusion:68Ga-PSMA-PET/CT is superior in the detection of LNM compared to 18F-choline-PET/CT. Whether those results will lead to an improved patient outcome after 68Ga-PSMA-PET-guided therapy needs to be investigated by further studies.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2019 Jan 25 [Epub ahead of print]

Cordula Annette Jilg, Vanessa Drendel, Hans Christian Rischke, Teresa Isabella Rosa Beck, Kathrin Reichel, Malte Krönig, Ulrich Wetterauer, Wolfgang Schultze-Seemann, Philipp Tobias Meyer, Werner Vach

Department of Urology, Medical Center - University of Freiburg, Faculty of Medicine, Germany., Institute for Pathology, Faculty of Medicine, University of Freiburg, Germany., Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, Germany., Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, Germany., Department of Orthopedics and Traumatology, University Hospital Basel, Switzerland.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe